Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples